Theriva Biologics Inc (TOVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -25,653 | -18,349 | -19,685 | -14,268 | -10,116 |
| Depreciation Amortization | 5,731 | 135 | 85 | 87 | 201 |
| Income taxes - deferred | N/A | -1,640 | -1,425 | N/A | N/A |
| Accounts payable and accrued liabilities | 123 | -157 | -385 | -363 | -1,429 |
| Other Working Capital | 726 | 2,309 | -806 | 709 | -2,781 |
| Other Operating Activity | 2,136 | -1,294 | 3,134 | 945 | 1,957 |
| Operating Cash Flow | $-16,937 | $-18,996 | $-19,082 | $-12,890 | $-12,168 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1 | -202 | -116 | -14 | -9 |
| Net Acquisitions | N/A | N/A | -3,863 | N/A | N/A |
| Other Investing Activity | 0 | 0 | -417 | 0 | 0 |
| Investing Cash Flow | $-1 | $-202 | $-4,396 | $-14 | $-9 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -67 | -75 | -1,376 | N/A | N/A |
| Common Stock Issued | 5,563 | 2,219 | N/A | 74,002 | 3,359 |
| Common Stock Repurchased | N/A | N/A | -288 | N/A | N/A |
| Other Financing Activity | 0 | -1,519 | -266 | 0 | 0 |
| Financing Cash Flow | $5,496 | $625 | $-1,930 | $74,002 | $3,359 |
| Exchange Rate Effect | -132 | -33 | -32 | N/A | N/A |
| Beginning Cash Position | 23,279 | 41,885 | 67,325 | 6,227 | 15,045 |
| End Cash Position | 11,705 | 23,279 | 41,885 | 67,325 | 6,227 |
| Net Cash Flow | $-11,574 | $-18,606 | $-25,408 | $61,098 | $-8,818 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,937 | -18,996 | -19,082 | -12,890 | -12,168 |
| Capital Expenditure | -1 | -202 | -116 | -14 | -9 |
| Free Cash Flow | -16,938 | -19,198 | -19,198 | -12,904 | -12,177 |